Pharmaceutical Executive March 6, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, dives into the greatest threats to the integrity of data in R&D and threats presented by hackers.

In a world rife with optimism about the good that AI can do, what threat is presented to pharma by bad actors, like hackers, but for their own nefarious purposes?

AI brings a lot of potential benefits, AI accelerates a lot of thinking, it can contemplate a lot of data, it can, it can help us, you know, filter out things. And I’m not going to go into the cautions of AI in the drug discovery process. But I’ll talk about the way AI. The way we use AI or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Cybersecurity, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy

Share This Article